We are live on
!
Find out more
AA
AlphaCentric Advisors Portfolio holdings
AUM
$100M
This Fund
S&P 500
This Quarter
Est. Return
+8.22%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$100M
AUM Growth
–
Cap. Flow
+$100M
Cap. Flow
% of AUM
100.06%
Top 10 Holdings %
Top 10 Hldgs %
20.66%
Holding
249
New
249
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$2.64M |
| 2 |
Invitation Homes
INVH
|
+$2.51M |
| 3 |
iShares MBS ETF
MBB
|
+$2.48M |
| 4 |
Euronet Worldwide
EEFT
|
+$2.17M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$2.01M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 40.96% |
| 2 | Technology | 10.32% |
| 3 | Real Estate | 9.94% |
| 4 | Industrials | 7.65% |
| 5 | Financials | 4.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Cisco
CSCO
$436B
| $248K | 0.25% |
+3,220
| New | +$239K |
|
127
Northern Trust
NTRS
$33.8B
| $242K | 0.24% |
+1,771
| New | +$233K |
|
128
Wabtec
WAB
$43.8B
| $240K | 0.24% |
+1,124
| New | +$231K |
|
129
Nasdaq
NDAQ
$52B
| $239K | 0.24% |
+2,458
| New | +$221K |
|
130
Icon
ICLR
$12.8B
| $236K | 0.24% |
+1,295
| New | +$231K |
|
131
Williams Companies
WMB
$90.7B
| $232K | 0.23% |
+3,863
| New | +$234K |
|
132
Arbutus Biopharma
ABUS
$871M
| $231K | 0.23% |
+47,925
| New | +$216K |
|
133
MeiraGTx Holdings
MGTX
$1.13B
| $227K | 0.23% |
+28,496
| New | +$237K |
|
134
Capital One
COF
$127B
| $223K | 0.22% |
+921
| New | +$205K |
|
135
Kinross Gold
KGC
$26.9B
| $218K | 0.22% |
+7,731
| New | +$201K |
|
136
Kinder Morgan
KMI
$72.5B
| $216K | 0.22% |
+7,871
| New | +$213K |
|
137
CME Group
CME
$88.6B
| $211K | 0.21% |
+774
| New | +$210K |
|
138
Vanguard Real Estate ETF
VNQ
$39.4B
| $205K | 0.2% |
+2,319
| New | +$208K |
|
139
Vanguard Global ex-US Real Estate ETF
VNQI
$3.47B
| $203K | 0.2% |
+4,430
| New | +$209K |
|
140
Abbott
ABT
$177B
| $200K | 0.2% |
+1,600
| New | +$204K |
|
141
Packaging Corp of America
PKG
$20.4B
| $198K | 0.2% |
+961
| New | +$195K |
|
142
TechnipFMC
FTI
$28.7B
| $197K | 0.2% |
+4,423
| New | +$187K |
|
143
Cullinan Oncology
CGEM
$1.08B
| $197K | 0.2% |
+19,041
| New | +$172K |
|
144
Allstate
ALL
$65.3B
| $193K | 0.19% |
+928
| New | +$190K |
|
145
Intercontinental Exchange
ICE
$80.1B
| $192K | 0.19% |
+1,185
| New | +$186K |
|
146
Automatic Data Processing
ADP
$102B
| $191K | 0.19% |
+742
| New | +$198K |
|
147
Design Therapeutics
DSGN
$741M
| $190K | 0.19% |
+20,262
| New | +$159K |
|
148
Robinhood
HOOD
$89.1B
| $188K | 0.19% |
+1,662
| New | +$216K |
|
149
VeriSign
VRSN
$25.3B
| $184K | 0.18% |
+756
| New | +$190K |
|
150
Artivion
AORT
$1.23B
| $183K | 0.18% |
+4,015
| New | +$179K |
|
Similar funds
WCM
FCM
BIA
AGAM
E
HCM
AC
OIS
AlphaCentric Advisors's Q4 2025 Portfolio in Review
Q4 2025 is the first quarter with a 13F filing on record for AlphaCentric Advisors, which disclosed 249 positions worth $100M. Its ten largest holdings account for 21% of the portfolio.
Its largest position is Gilead Sciences: 21,761 shares worth $2.67M.
By sector, the portfolio is most concentrated in Healthcare at 41% of assets, followed by Technology and Real Estate.
- AlphaCentric Advisors's largest Q4 2025 buy was Gilead Sciences: 21,761 shares worth $2.67M.
- AlphaCentric Advisors's ten largest holdings make up 21% of its $100M portfolio in Q4 2025.
- AlphaCentric Advisors disclosed 249 positions in Q4 2025, its first 13F filing on record.
Based on AlphaCentric Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.